Total Payments
$3,271
2024 Payments
$81.12
Companies
12
Transactions
25
Medicare Patients
5,941
Medicare Billing
$2.0M
Payment Breakdown by Category
Travel$1,740 (53.2%)
Food & Beverage$1,374 (42.0%)
Education$158.20 (4.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,740 | 4 | 53.2% |
| Food and Beverage | $1,374 | 16 | 42.0% |
| Education | $158.20 | 5 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $1,952 | 6 | $0 (2018) |
| Alcon Laboratories Inc | $341.80 | 2 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $274.90 | 5 | $0 (2024) |
| Mallinckrodt LLC | $238.80 | 2 | $0 (2018) |
| ABBVIE INC. | $124.25 | 1 | $0 (2022) |
| Genentech, Inc. | $101.60 | 1 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $61.52 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $52.98 | 2 | $0 (2019) |
| Johnson & Johnson Surgical Vision, Inc. | $46.92 | 1 | $0 (2022) |
| Travere Therapeutics, Inc. | $33.45 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $81.12 | 4 | Regeneron Healthcare Solutions, Inc. ($60.39) |
| 2023 | $146.69 | 2 | Regeneron Healthcare Solutions, Inc. ($124.52) |
| 2022 | $204.62 | 4 | ABBVIE INC. ($124.25) |
| 2019 | $127.16 | 2 | Genentech, Inc. ($101.60) |
| 2018 | $2,440 | 11 | Regeneron Pharmaceuticals, Inc. ($1,952) |
| 2017 | $272.35 | 2 | Alcon Laboratories Inc ($157.11) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Education | In-kind items and services | $20.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Education | In-kind items and services | $19.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Education | In-kind items and services | $19.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/02/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Ophthalmology | ||||||
| 10/06/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $124.52 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/22/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: DRY EYE | ||||||
| 12/09/2022 | Travere Therapeutics, Inc. | Cholbam (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Hepatology | ||||||
| 10/25/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $124.25 | General |
| 09/09/2022 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Simplicity (Device) | Food and Beverage | In-kind items and services | $46.92 | General |
| Category: Optics | ||||||
| 04/07/2022 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $7.82 | General |
| Category: Hepatology | ||||||
| 06/10/2019 | Genentech, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $101.60 | General |
| Category: Ophthalmology | ||||||
| 03/11/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $25.56 | General |
| 11/26/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $123.56 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 10/28/2018 | Novartis Pharmaceuticals Corporation | BROLUCIZUMAB (Drug), BROLUCIZUMAB | Food and Beverage | In-kind items and services | $27.42 | General |
| 09/07/2018 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Education | In-kind items and services | $89.99 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/13/2018 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $500.00 | General |
| 07/20/2018 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $339.58 | General |
| 07/19/2018 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $61.84 | General |
| 06/18/2018 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $500.00 | General |
| 06/18/2018 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $150.92 | General |
| 04/27/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VISUDYNE (Drug) | Food and Beverage | In-kind items and services | $61.52 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/14/2018 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $400.00 | General |
| 04/09/2018 | Alcon Laboratories Inc | Constellation (Device) | Food and Beverage | In-kind items and services | $184.69 | General |
| Category: Ophthalmology | ||||||
| 12/11/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $115.24 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 07/21/2017 | Alcon Laboratories Inc | — | Food and Beverage | In-kind items and services | $157.11 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,520 | 3,381 | $1.4M | $538,498 |
| 2022 | 10 | 1,517 | 3,231 | $1.3M | $511,242 |
| 2021 | 12 | 1,528 | 3,314 | $1.2M | $506,371 |
| 2020 | 14 | 1,376 | 2,812 | $997,713 | $411,973 |
Total Patients
5,941
Total Services
12,738
Medicare Billing
$2.0M
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 83 | 530 | $974,670 | $363,658 | 37.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 296 | 653 | $137,783 | $84,388 | 61.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 104 | 300 | $100,683 | $27,008 | 26.8% |
| 92134 | Imaging of retina | Office | 2023 | 405 | 879 | $68,562 | $25,363 | 37.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 88 | 88 | $27,720 | $12,991 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 81 | $12,231 | $7,372 | 60.3% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 242 | 488 | $22,448 | $5,323 | 23.7% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 146 | 234 | $10,764 | $4,390 | 40.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $7,350 | $3,438 | 46.8% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 19 | 23 | $4,508 | $2,494 | 55.3% |
| 92250 | Photography of the retina | Office | 2023 | 51 | 75 | $7,425 | $2,071 | 27.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 74 | 484 | $890,076 | $343,334 | 38.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 253 | 518 | $109,402 | $68,679 | 62.8% |
| 92134 | Imaging of retina | Office | 2022 | 409 | 846 | $65,988 | $25,126 | 38.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 83 | 257 | $82,863 | $23,452 | 28.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 153 | 153 | $48,195 | $23,040 | 47.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 165 | $24,915 | $15,247 | 61.2% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 387 | 734 | $33,764 | $8,444 | 25.0% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 18 | 22 | $4,312 | $2,222 | 51.5% |
| 92250 | Photography of the retina | Office | 2022 | 28 | 35 | $3,465 | $1,052 | 30.4% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 15 | 17 | $2,771 | $644.95 | 23.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 61 | 460 | $845,940 | $337,375 | 39.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 223 | 468 | $70,668 | $47,649 | 67.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 122 | 211 | $44,521 | $28,489 | 64.0% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 381 | 875 | $68,250 | $27,271 | 40.0% |
About Dr. Zachary Bodnar, MD
Dr. Zachary Bodnar, MD is a Retina Specialist healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1609130772.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Zachary Bodnar, MD has received a total of $3,271 in payments from pharmaceutical and medical device companies, with $81.12 received in 2024. These payments were reported across 25 transactions from 12 companies. The most common payment nature is "Travel and Lodging" ($1,740).
As a Medicare-enrolled provider, Bodnar has provided services to 5,941 Medicare beneficiaries, totaling 12,738 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Location Henderson, NV
- Active Since 07/03/2012
- Last Updated 12/16/2019
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1609130772
Products in Payments
- ACTHAR (Biological) $238.80
- EYLEA HD (Biological) $184.91
- Constellation (Device) $184.69
- Lucentis (Biological) $101.60
- EYLEA AFLIBERCEPT INJECTION (Biological) $89.99
- VISUDYNE (Drug) $61.52
- Tecnis Simplicity (Device) $46.92
- Cholbam (Drug) $33.45
- BROLUCIZUMAB (Drug) $27.42
- TYRVAYA (Drug) $22.17
- XIIDRA (Drug) $20.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.